Martin R. Schipperus

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 851 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +9

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

Michael Hedenus, Magnus Adriansson, Jesús F. San Miguel et al. · British Journal of Haematology · 2003 · 325 citations · Full text

Hematopoietic stem cell transplantation for multiple sclerosis

Jakob Passweg, A. Kazis, Tomáš Kozák et al. · Journal of Neurology · 2002 · 262 citations

Cell Therapy, Transplantation, Marrow Transplantation +8

Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction

Jean‐Louis H. Kerkhoffs, Wim L.J. van Putten, Viera M. J. Novotny et al. · British Journal of Haematology · 2010 · 166 citations · Full text

Immunohematology, Summary Pathogen Reduction, Platelet Pathobiology +17

An open‐label, unit dose‐finding study of AMG 531, a novel thrombopoiesis‐stimulating peptibody, in patients with immune thrombocytopenic purpura

Adrian C. Newland, Marie Thérèse Caulier, M. C. Kappers‐Klunne et al. · British Journal of Haematology · 2006 · 149 citations